These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21723634)

  • 1. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
    Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
    Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
    Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M
    J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.
    Bollineni VR; Kerner GS; Pruim J; Steenbakkers RJ; Wiegman EM; Koole MJ; de Groot EH; Willemsen AT; Luurtsema G; Widder J; Groen HJ; Langendijk JA
    J Nucl Med; 2013 Aug; 54(8):1175-80. PubMed ID: 23753185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy.
    Tran LB; Bol A; Labar D; Karroum O; Bol V; Jordan B; Grégoire V; Gallez B
    Radiother Oncol; 2014 Nov; 113(2):204-9. PubMed ID: 25434767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.
    Mortensen LS; Johansen J; Kallehauge J; Primdahl H; Busk M; Lassen P; Alsner J; Sørensen BS; Toustrup K; Jakobsen S; Petersen J; Petersen H; Theil J; Nordsmark M; Overgaard J
    Radiother Oncol; 2012 Oct; 105(1):14-20. PubMed ID: 23083497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
    Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
    Busk M; Horsman MR; Jakobsen S; Hansen KV; Bussink J; van der Kogel A; Overgaard J
    Radiother Oncol; 2009 Sep; 92(3):429-36. PubMed ID: 19729214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study.
    Tran LB; Bol A; Labar D; Cao-Pham TT; Jordan B; Grégoire V; Gallez B
    Radiother Oncol; 2015 Feb; 114(2):189-94. PubMed ID: 25616539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.
    Trinkaus ME; Blum R; Rischin D; Callahan J; Bressel M; Segard T; Roselt P; Eu P; Binns D; MacManus MP; Ball D; Hicks RJ
    J Med Imaging Radiat Oncol; 2013 Aug; 57(4):475-81. PubMed ID: 23870348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.
    Servagi-Vernat S; Differding S; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
    Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1544-52. PubMed ID: 24570097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck tumor hypoxia imaging by 18F-fluoroazomycin-arabinoside (18F-FAZA)-PET: a review.
    Halmos GB; Bruine de Bruin L; Langendijk JA; van der Laan BF; Pruim J; Steenbakkers RJ
    Clin Nucl Med; 2014 Jan; 39(1):44-8. PubMed ID: 24152663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with
    Han K; Shek T; Vines D; Driscoll B; Fyles A; Jaffray D; Keller H; Metser U; Pintilie M; Xie J; Yeung I; Milosevic M
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1202-1209. PubMed ID: 29680257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
    Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
    Busk M; Mortensen LS; Nordsmark M; Overgaard J; Jakobsen S; Hansen KV; Theil J; Kallehauge JF; D'Andrea FP; Steiniche T; Horsman MR
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):186-97. PubMed ID: 23076620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
    Mortensen LS; Buus S; Nordsmark M; Bentzen L; Munk OL; Keiding S; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):934-40. PubMed ID: 20831480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.
    Busk M; Munk OL; Jakobsen S; Wang T; Skals M; Steiniche T; Horsman MR; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):922-33. PubMed ID: 20831479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).
    Maier FC; Kneilling M; Reischl G; Cay F; Bukala D; Schmid A; Judenhofer MS; Röcken M; Machulla HJ; Pichler BJ
    Radiat Oncol; 2011 Nov; 6():165. PubMed ID: 22118419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia imaging with
    Melsens E; De Vlieghere E; Descamps B; Vanhove C; Kersemans K; De Vos F; Goethals I; Brans B; De Wever O; Ceelen W; Pattyn P
    Radiat Oncol; 2018 Mar; 13(1):39. PubMed ID: 29514673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
    Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
    J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.